How Much Does Wegovy Slow Down Digestion, and Why Does It Affect Your Treatment Costs?

Step 1: understand what the digestion-slowing mechanism means for your dosing timeline, and therefore your spend

Wegovy's GLP-1 receptor agonist action does two related things: it reduces appetite signals from the brain and it slows gastric emptying, so food moves from stomach to small intestine more gradually. The slower the emptying, the longer you feel full, and the less likely you are to eat past your energy needs. This isn't instantaneous. Semaglutide follows a mandatory titration schedule (starting at 0.25mg weekly and stepping up through 0.5mg, 1.0mg and 1.7mg before reaching the standard 2.4mg maintenance dose) with roughly four weeks at each level. The prescriber controls the pace; rushing it increases GI side effects such as nausea and vomiting without improving results. That means a minimum of roughly five months before you reach maintenance dose, and the full picture of how Wegovy works covers the mechanism in more detail. If you want to understand how much Wegovy costs across that titration journey, the figures shift meaningfully as your dose increases. Private cost is therefore not a single transaction, it's a sequence of monthly pens, each reviewed before it ships.

The STEP 1 trial, published in the New England Journal of Medicine, found participants lost an average of around 15% of body weight over 68 weeks on 2.4mg semaglutide alongside lifestyle changes. That trial timeframe is a useful anchor for realistic cost planning.

Step 2: read the actual UK private market pricing, hedged, because it moves

Private Wegovy pricing in the UK varies by dose and by provider. Lower doses cost less per pen; the maintenance pens at 1.7mg and 2.4mg sit at a higher price point. As a broad, hedged reference: market rates have typically ranged from around £149 to £375 per month depending on dose and service, with significant variation between providers. Those figures shift, Eli Lilly's September 2025 list price increase for tirzepatide pushed the wider market's reference points upward, and Novo Nordisk pricing follows its own trajectory. For dose-specific context, what Wegovy costs per month across the full schedule breaks this down clearly, and the 2.4mg pen specifically has its own dedicated page.

One number you'll see quoted often is the per-pen headline price. That number is only the starting point. A legitimate private service includes clinical assessment before every supply, not just the first one. Without that, it isn't a legal prescription pathway.

Step 3: check what a headline price actually covers

A low headline price for a prescription medicine is worth interrogating. Legitimate private services must include a prescriber's clinical assessment and an issued prescription; some providers charge for these separately, or add delivery fees, or bill for aftercare consultations when doses need adjusting. The total figure across a realistic treatment period (which the STEP 1 data suggests runs well beyond six months for meaningful results) can look quite different from the monthly lead price in a comparison search.

Common exclusions to look for: consultation fees billed per appointment, delivery charges (especially for temperature-controlled medicines that need tracked courier handling), and support costs if you develop side effects and need clinical guidance mid-month. The broader cost picture for semaglutide covers these variables, and the 1.7mg dose pricing page is useful for readers mid-titration.

At nume, the price shown on the treatment page covers consultation, prescription, the medicine, and next-working-day delivery. There are no hidden fees. No subscription auto-renewals. Every repeat is reviewed by a prescriber before it goes anywhere.

Why cheapest is the wrong test for a gastric-emptying medicine that ships cold

Semaglutide pens require cold-chain storage. A pen that has been stored outside the correct temperature range may look identical but perform differently. The MHRA has warned publicly about counterfeit weight-loss pens sold through unverified online channels, some containing entirely the wrong substance. For a medicine that works by precisely modulating a gut-hormone pathway, the supply chain provenance matters enormously. You can verify any UK online pharmacy on the GPhC pharmacy register; a legitimate pharmacy will have a registered premises number displayed. Suspect sellers (those offering these medicines without a clinical assessment, via social media, or at prices far below market) should be reported through the MHRA's Yellow Card scheme.

nume's pharmacy is GPhC-registered (premises number 9012878, verifiable directly on the GPhC register). Medicines come through the licensed UK supply chain. Your pen arrives in plain, unbranded packaging via DPD with a tracking link, you know exactly when it's coming and what to expect when it does. We're not the cheapest provider in this market. That's a deliberate choice: the infrastructure that keeps a cold-chain prescription medicine safe and legally supplied has a cost, and we'd rather be transparent about it than shave margins in places that matter. More about how nume works is on our about page, or you can read about the clinical team's approach on our prescriber profile.

For anyone ready to find out whether Wegovy suits their circumstances, the right next step is a clinical assessment, not a price comparison. Check your eligibility with a free consultation.